|Bid||6.26 x 600|
|Ask||6.27 x 400|
|Day's Range||6.17 - 6.33|
|52 Week Range||5.28 - 9.86|
|PE Ratio (TTM)||-5.83|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||11.83|
NEW YORK, NY / ACCESSWIRE / September 22, 2017 / U.S. markets retreated from record highs a day after the Federal Reserve announced that it would begin unwinding its $4.5 trillion balance sheet in October ...
Inovio Pharmaceuticals Inc. shares climbed about 5% in premarket trade Thursday, after the company said its DNA-based monoclonal antibody program (dMAb) has been boosted by two peer-reviewed scientific ...
PLYMOUTH MEETING, Pa., Sept. 21, 2017-- Inovio Pharmaceuticals, Inc. today announced that the development of its DNA-based monoclonal antibody program received a boost from two peer-reviewed scientific ...